Better Therapeutics, Inc.
BTTX
$0.0002
$0.000.00%
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -70.42% | -79.13% | -80.84% | -61.20% | 590.13% |
Total Receivables | 17.74% | -16.67% | 53.79% | -83.70% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -39.98% | -51.01% | -39.30% | -43.39% | 319.03% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -68.73% | -76.91% | -76.00% | -59.24% | 318.12% |
|
|||||
Total Current Assets | -68.73% | -76.91% | -76.00% | -59.24% | 318.12% |
Net Property, Plant & Equipment | -16.39% | 0.00% | 33.67% | 47.56% | 100.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -32.25% | -17.87% | -17.10% | -23.42% | -19.42% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -1.02% | -0.82% | -1.02% | -10.95% | 136.89% |
Total Assets | -62.01% | -68.72% | -68.21% | -54.98% | 156.58% |
|
|||||
Total Accounts Payable | 83.90% | 174.36% | 241.90% | 99.28% | -62.62% |
Total Accrued Expenses | -17.94% | 58.87% | 121.04% | 84.64% | 215.49% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 110.48% | 219.29% | 1,722.04% | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 38.94% | 125.91% | 282.39% | 185.10% | 89.31% |
|
|||||
Total Current Liabilities | 38.94% | 125.91% | 282.39% | 185.10% | 89.31% |
Long-Term Debt | -33.77% | -34.00% | -3.20% | 8.87% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -1.48% | 17.55% | 75.98% | 67.45% | -52.47% |
|
|||||
Common Stock & APIC | 13.08% | 7.56% | 2.02% | 1.97% | 20,613.75% |
Retained Earnings | -30.73% | -40.64% | -48.47% | -55.42% | -77.60% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -237.02% | -159.75% | -135.85% | -102.45% | 112.65% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -237.02% | -159.75% | -135.85% | -102.45% | 112.65% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -237.02% | -159.75% | -135.85% | -102.45% | 121.90% |
|